Increasing Prevalence of Oral Diseases Worldwide to Augment the Benzocaine Market Growth
Benzocaine (also known as anaesthesin or americaine) is an active pharmaceutical ingredient that belongs to the class of organic compounds known as benzoic acid esters. It has various medicinal properties. Benzocaine is used as a pain relief drug in dental diseases such as dental caries and tooth decay, topical anesthetic in various diseases such as esophageal and mouth ulcers, for sexual disorders such as premature ejaculation, and to get rid of skin irritation such as vaginal irritation. Benzocaine is slightly soluble in water, manufactured in solid physical form, and its chemical name is Ethyl 4-aminobenzoate.
Worldwide,
the increasing prevalence of oral/dental diseases (such as dental trauma,
dental caries, and periodontitis) is driving the growth of the market. Oral
diseases pose a major health burden for many countries and affect people
throughout their lives, which may lead to heartburn, discomfort, pain, and even
death. According to the World Health Organization (WHO), in 2017, oral diseases
affect around 3.5 billion people and around 530 million children suffer from
dental caries worldwide. Moreover, the increase in the prevalence of oral ulcers
worldwide is also expected to propel the benzocaine market growth. In the U.K.,
20% of the population are believed to be affected by recurrent aphthous
ulceration.
The outbreak
of COVID-19 (coronavirus) has affected almost every market and has also
impacted the benzocaine
market. The outbreak has affected the production and demand, as well as
created disruptions in distribution channels. Manufacturing and supply chain activities
in the U.S., China, and India have been disrupted due to nationwide lockdowns. However, in terms of geography, the benzocaine market is divided into six regions, such as North
America, Europe, Asia Pacific, South America, the Middle East, and Africa.
North
America is expected to witness substantial growth in the market due to the
increasing product approvals and the presence of major key players in the
region. Moreover, Key players active in the market are adopting various growth
strategies (such as product launches, mergers and acquisitions, collaboration,
etc.) to strengthen their market presence or to strengthen their product
portfolio. For instance, in March 2019, Church and Dwight launched a new RepHresh
Cooling Relief Vaginal Anti-Itch Spray to expand its product offerings. The new
spray is meant to relieve feminine itch and neutralize odor, providing relief
on contact, the company said.
Comments
Post a Comment